Almado, Inc.
TTSE:4932740.00
JPY
+10.00
(+1.37%)
Almado, Inc.
TSE:4932
(Tokyo Stock Exchange)
Recent
price
740.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.- Similar Companies
- Business
- Almado Inc (TSE:4932) plans, develops, sells cosmetics, supplements, and quasi-drugs derived primarily from eggshell membrane materials in Japan, with all production outsourced. Core products include skincare such as whitening serum, moisturizing eggshell membrane serum, wrinkle-reducing and firmness-enhancing creams, facial cleansing with electrolyzed water, brightening lotions, hyaluronic acid spicules, and beauty drinks; hair growth supplements; and other beauty foods under brands including TO-II, Ode series, CELLULA, Type III, AMF, and Almado La Dina; the company also provides original equipment manufacturing (OEM) services and wholesale. It operates through television shopping channels such as QVC, external indirect sales to drug stores, hairdressers, and mail order firms, and in-house direct sales via proprietary and third-party e-commerce sites, targeting individual consumers seeking health and beauty solutions based on eggshell membrane biotechnology. Founded in 2000 and headquartered at 3-6-18 Kyobashi, 8F Tokyo Tatemono Kyobashi Building, Chuo-ku, Tokyo, Japan, Almado maintains a focused eggshell membrane healthcare segment with approximately 71 employees. Recent major changes encompass strategic ownership shifts including CBC Co Ltd's acquisition of an additional 10.26% stake in 2022 from Ant Capital Partners-managed funds, alongside ongoing research advancements and product promotions through key channels without noted new partnerships, funding rounds, or expansions in 2024-2025.